Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-28T16:49:00.811Z Has data issue: false hasContentIssue false
  • English
  • Français

Individually customised parametrial boost for locally advanced cervical cancer: is 2D planned external beam radiotherapy useful?

Published online by Cambridge University Press:  09 August 2019

Aparna Gangopadhyay Open the ORCID record for Aparna Gangopadhyay [Opens in a new window]  and
Subrata Saha
Aparna Gangopadhyay*
Affiliation:
Department of Radiotherapy, Chittaranjan National Cancer Institute, Kolkata, India
Subrata Saha
Affiliation:
Department of Radiotherapy, Medical College Hospitals, Kolkata, India
*
Author for correspondence: Aparna Gangopadhyay, Department of Radiotherapy, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India. Tel: +91 9836386469. Fax: 0091 33 2541 0088. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Aim:

Pelvic wall control and toxicity was retrospectively assessed in patients who received individually customised parametrial boost (PMB) for locally advanced cervical cancer with 2D planned external beam radiotherapy. Outcomes of a dose-escalated combined boost were also evaluated.

Materials and methods:

Toxicity and pelvic wall recurrence was evaluated over a median period of 24 months between two groups who received different pelvic wall doses. One group was randomised to receive either intracavitary brachytherapy (ICRT) with an external beam PMB using a customised midline shield, or a dose-escalated combined boost with interstitial brachytherapy (ISBT) and PMB. The comparator group received no PMB.

Results:

At 24 months, pelvic wall recurrence occurred in 2/112 and 40/130 with and without PMB, respectively (p < 0·000001). No significant difference in toxicity was noted between boost versus no-boost groups (p = 0·56). Combined ISBT/PMB dose escalation showed no significant difference in pelvic wall recurrence compared with PMB alone (p = 0·49).

Findings:

Individually customised 2D PMBs with 3D image-based ICRT was safe and improved pelvic wall control in locally advanced cervix cancer. Dose-escalated combined boosts offered no significant benefit over standard boost doses.

Keywords

3D image-based brachytherapyinterstitial brachytherapylocally advanced cervical cancerparametrial boost
Type
Original Article
Information
Journal of Radiotherapy in Practice , Volume 19 , Issue 3 , September 2020 , pp. 248 - 253
Copyright
© Cambridge University Press 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Marth, C, Landoni, F, Mahner, S, McCormack, M, Gonzalez-Martin, A, Colombo, N, ESMO Guidelines Committee. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28 (suppl_4): iv72–iv83. doi: 10.1093/annonc/mdx220. PubMed PMID: 28881916.CrossRefGoogle ScholarPubMed
Gupta, S, Parab, P, Kerkar, Ret al.928O_PR Neoadjuvant chemotherapy followed by surgery (NACT-surgery) versus concurrent cisplatin and radiation therapy (CTRT) in patients with stage IB2 to IIB squamous carcinoma of cervix: a randomized controlled trial (RCT). Ann Oncol 2017; 28 (suppl_5): v605–v649, mdx440.038, 10.1093/annonc/mdx440.038CrossRefGoogle Scholar
Perez, C A, Grigsby, P W, Camel, H Met al.Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of the uterine cervix: update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 1995; 31: 703–716.CrossRefGoogle ScholarPubMed
Ferlay, J, Soerjomataram, I, Ervik, Met al. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer, 2013.Google Scholar
Bruni, L, Barrionuevo-Rosas, L, Albero, Get al. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in India. Summary report 27 July 2017, 2018.Google Scholar
Pötter, R, Haie-Meder, C, Van Limbergen, Eet al.GEC ESTRO Working Group. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78 (1): 67–77. Epub 5th January 2006. PubMed PMID: 16403584.CrossRefGoogle Scholar
Huang, E Y, Wang, C J, Hsu, H C, Lin, H, Chen, H C, Sun, L M.Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose. Gynecol Oncol 2004; 95 (1): 101–108. PubMed PMID: 15385117.CrossRefGoogle Scholar
Fenkell, L, Assenholt, M, Nielsen, S Ket al.Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2011; 79 (5): 1572–1579. doi: 10.1016/j.ijrobp.2010.05.031. Epub 26th August 2010. PubMed PMID: 20800373.CrossRefGoogle Scholar
Mohamed, S, Kallehauge, J, Fokdal, L, Lindegaard, J C, Tanderup, K.Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy. Brachytherapy 2015; 14 (1): 23–28. doi: 10.1016/j.brachy.2014.09.010. Epub 8th November 2014. PubMed PMID: 25455382.CrossRefGoogle ScholarPubMed
Pecorelli, S.Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105 (2): 103–104. PubMed PMID: 19367689.CrossRefGoogle ScholarPubMed
Patel, F D, Rai, B, Mallick, I, Sharma, S C.High-dose-rate brachytherapy in uterine cervical carcinoma. Int J Radiat Oncol Biol Phys 2005; 62 (1): 125–130. PubMed PMID: 15850912.CrossRefGoogle ScholarPubMed
Patel, F D, Kumar, P, Karunanidhi, G, Sharma, S C, Kapoor, R.Optimization of high-dose-rate intracavitary brachytherapy schedule in the treatment of carcinoma of the cervix. Brachytherapy 2011; 10 (2): 147–153. doi: 10.1016/j.brachy.2010.05.003. Epub 4th August 2010. PubMed PMID: 20685179.CrossRefGoogle ScholarPubMed
Sood, B M, Gorla, G, Gupta, Set al.Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy. Int J Radiat Oncol Biol Phys 2002; 53 (3): 702–706. PubMed PMID: 12062615.CrossRefGoogle ScholarPubMed
Cox, J D, Stetz, J, Pajak, T F.Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31 (5): 1341–1346. PubMed PMID: 7713792.CrossRefGoogle Scholar
International Commission on Radiation Units and Measurements (ICRU). Dose and volume specification for reporting intracavitary brachytherapy in gynecology (Report 38), 1985.Google Scholar
Wolfson, A H, Abdel-Wahab, M, Markoe, A Met al.A quantitative assessment of standard vs. customized midline shield construction for invasive cervical carcinoma. Int J Radiat Oncol Biol Phys 1997; 37 (1): 237–242. PubMed PMID: 9054901.CrossRefGoogle ScholarPubMed
Popple, R A, Kim, R Y, Pareek, P, Duan, J, Shen, S, Brezovich, I A.Custom step wedge blocking using dynamic multileaf collimation for parametrial pelvic boost irradiation following brachytherapy for carcinoma of the cervix. Med Phys 2003; 30 (10): 2699–2702. PubMed PMID: 14596307.CrossRefGoogle ScholarPubMed
Yin, G, Wang, P, Lang, Jet al.Dosimetric study for cervix carcinoma treatment using intensity modulated radiation therapy (IMRT) compensation based on 3D intracavitary brachytherapy technique. J Contemp Brachytherapy 2016; 8 (3): 221–232. doi: 10.5114/jcb.2016.60590. Epub 14th June 2016. PubMed PMID: 27504132; PubMed Central PMCID: PMC4965499.CrossRefGoogle ScholarPubMed
Cheng, J Y, Huang, E Y, Hsu, S N, Wang, C J.Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach. Br J Radiol 2016; 89 (1068): 20160526. Epub 6th October 2016. PubMed PMID: 27706947; PubMed Central PMCID: PMC5604918.CrossRefGoogle ScholarPubMed
Rajasooriyar, C, Van Dyk, S, Lindawati, M, Bernshaw, D, Kondalsamy-Chennakesavan, S, Narayan, K.Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography. Int J Gynecol Cancer 2012; 22 (9): 1532–1537. doi: 10.1097/IGC.0b013e31826c4dee. PubMed PMID: 23027037.Google ScholarPubMed